JANICE FERLITCH: Open Payments
NPI 1790048171 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 9 payments from 9 companies in 2025. Trend: 2023 $1,669 · 2024 $903 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $140 |
| Exelixis Inc. | 1 | $123 |
| CeQur Corporation | 1 | $122 |
| Amgen Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| SANOFI-AVENTIS U.S. LLC | 1 | $111 |
| Sage Therapeutics, LLC | 1 | $99 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $97 |
| Janssen Pharmaceuticals, Inc | 1 | $88 |
Products named: TREMFYA, CABOMETYX, CeQur Simplicity, TAVNEOS, FASENRA, TZIELD, SPRAVATO.
Industry payments across MD — which companies pay providers there.
